Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The 56 Point TA; Charts With an Attitude -- Ignore unavailable to you. Want to Upgrade?

To: RWS who wrote (25979)	1/28/1999 2:32:00 PM
From: David Haith	Respond to of 79230

BJCT This was in the Q3 news release which to me hints a little as to things coming. ''We are focusing our business development efforts on forging long-term relationships with significant corporate partners and our sales efforts on targeted, high leverage product sales opportunities,'' said Jim O'Shea, chairman, president and chief executive officer of Bioject. ''This approach has resulted in a short-term decline in product revenue that has been more than offset by an increase in licensing revenue. We are confident that this strategy is the most effective way to deploy the company's resources, and will lead to sustained revenues for the company in the future.'' David